Helix Biopharma holder sells 800,000 shares, cutting stake to about 9.88%
Major holder Jerzy Wilczewski sold 800,000 Helix Biopharma shares at C$1.30 in a private sale, per TradingView, cutting his stake to about 9.88%.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
A significant shareholder, Jerzy Wilczewski, disposed of 800,000 Helix shares priced at C$1.30 through a negotiated off-market transfer, TradingView reports. His holding dropped to 7,548,986 shares, roughly 9.88% compared with 10.93% previously. He also retains 1,260 convertible debentures maturing on August 2, 2027.
why it matters
The move reflects a trimmed position by a large holder rather than any change in the company's operations or guidance. Off-market transfers usually have less immediate effect on trading volume. Traders may watch for further sales, a crossing of the 10% reporting threshold, or conversion terms on the debentures.
tags
instruments
sources
- Helix Biopharma Corp. (HBP) Holder Cuts Stake by 800K Shares — TradingView, 19 October 2026 at 21:15 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗